Title
Paving Plant-Food-Derived Bioactives as Effective Therapeutic Agents in Autism Spectrum Disorder
Date Issued
01 January 2021
Access level
open access
Resource Type
review
Author(s)
Cruz-Martins N.
Kirkin C.
Şenol E.
Zuluǧ A.
Özçelik B.
Ademiluyi A.O.
Oyeniran O.H.
Semwal P.
Kumar M.
Sharopov F.
López V.
Les F.
Bagiu I.C.
Butnariu M.
Sharifi-Rad J.
Alshehri M.M.
Cho W.C.
Universidad Arturo Prat
Publisher(s)
Hindawi Limited
Abstract
Autism spectrum disorder (ASD) is a neurodevelopmental disorder, where social and communication deficits and repetitive behaviors are present. Plant-derived bioactives have shown promising results in the treatment of autism. In this sense, this review is aimed at providing a careful view on the use of plant-derived bioactive molecules for the treatment of autism. Among the plethora of bioactives, curcumin, luteolin, and resveratrol have revealed excellent neuroprotective effects and can be effectively used in the treatment of neuropsychological disorders. However, the number of clinical trials is limited, and none of them have been approved for the treatment of autism or autism-related disorder. Further clinical studies are needed to effectively assess the real potential of such bioactive molecules.
Volume
2021
Language
English
OCDE Knowledge area
Otras ciencias médicas
Neurociencias
Scopus EID
2-s2.0-85114610989
PubMed ID
Source
Oxidative Medicine and Cellular Longevity
ISSN of the container
19420900
Sources of information:
Directorio de Producción Científica
Scopus